#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12904	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2210	580.3	0	.	n	.	0	A69G	SNP	69	69	A	279	279	G	766	G,A	713,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12904	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2210	580.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1660	1660	T	716	T,C	664,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12904	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2210	580.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1394	1394	C	771	C	709	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12904	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2210	580.3	0	HET	.	.	.	C751T	.	751	751	C	961	961	C	729	C,T	549,123	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12904	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2210	580.3	0	HET	.	.	.	A320G	.	320	320	A	530	530	A	672	A,G	428,195	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23336	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3516	661.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1710	1710	A	808	A	752	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23336	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3516	661.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	691	C,A,T	648,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23336	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3516	661.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	739	A	692	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23336	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3516	661.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	763	C,T	719,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1560	folP	852	852	99.88	folP.l15.c30.ctg.1	1576	98.6	0	.	p	.	0	E151K	NONSYN	451	453	GAA	758	760	AAA	162;162;160	A,G;A;A	144,1;146;142	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	1560	folP	852	852	99.88	folP.l15.c30.ctg.1	1576	98.6	1	SNP	p	R228S	1	.	.	682	684	AGC	989	991	AGC	155;153;154	A;G;C	147;145;145	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4302	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3382	126.8	1	SNP	p	S91F	0	.	.	271	273	TCC	599	601	TCC	158;156;156	T;C;C	146;147;146	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4302	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3382	126.8	1	SNP	p	D95N	0	.	.	283	285	GAC	611	613	GAC	157;155;158	G;A;C	149;147;150	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4302	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3382	126.8	1	SNP	p	D95G	0	.	.	283	285	GAC	611	613	GAC	157;155;158	G;A;C	149;147;150	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1240	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1511	81.8	1	SNP	p	G45D	0	.	.	133	135	GGC	604	606	GGC	150;152;151	G;G;C	140;141;142	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	648	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	982	65.5	0	.	n	.	0	A197.	DEL	197	197	A	520	520	A	143	A	129	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4264	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2970	143.0	1	SNP	p	D86N	0	.	.	256	258	GAC	570	572	GAC	178;180;182	G;A;C	165;164;170	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4264	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2970	143.0	1	SNP	p	S87W	0	.	.	259	261	AGT	573	575	AGT	182;181;182	A;G;T	169;168;164	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4264	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2970	143.0	1	SNP	p	S87I	0	.	.	259	261	AGT	573	575	AGT	182;181;182	A;G;T	169;168;164	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4264	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2970	143.0	1	SNP	p	S87R	0	.	.	259	261	AGT	573	575	AGT	182;181;182	A;G;T	169;168;164	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4264	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2970	143.0	1	SNP	p	S88P	0	.	.	262	264	TCC	576	578	TCC	181;182;184	T;C;C	166;167;171	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3614	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2678	134.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1597	1599	GGC	171;172;173	G;G;C	159;158;160	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1312	1314	GCA	200;202;206	G;C;A	185;183;186	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1315	1317	ATC	207;207;209	A;T;C	187;188;190	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1327	1329	GTG	204;206;205	G;T;G	187;189;188	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1327	1329	GTG	204;206;205	G;T;G	187;189;188	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1831	1833	ACC	146;145;145	A;C;C	133;136;137	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1885	1887	GCG	152;149;151	G;C;G	130;116;124	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1885	1887	GCG	152;149;151	G;C;G	130;116;124	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2008	2010	GGC	137;133;137	G;G;C	128;122;127	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2017	2019	GGC	135;132;132	G;G;C	121;117;118	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3362	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2392	139.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2035	2037	CTG	132;136;137	C,G;T;G	103,5;100;113	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4930	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	2994	163.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1558	1560	CCG	171;172;172	C;C;G,A	149;155;151,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1760	porA	1146	1146	99.65	porA.l15.c17.ctg.1	1676	104.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	523	523	C	115	C	108	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	296	298	GAA	214;215;216	G;A;A	195;196;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	584	586	GAT	202;200;198	G;A;T	188;185;181	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	707	709	TCA	215;213;213	T;C;A	196;196;196	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	836	838	GTC	184;184;186	G;T;C,T	173;171;174,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1166	1168	GCA	220;219;216	G;C,A;A	206;205,2;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	1	SNP	p	G120K	1	.	.	358	360	AAG	542	544	AAG	214;213;210	A,G;A,G;G,T	197,1;198,2;192,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	1	SNP	p	A121D	1	.	.	361	363	GAC	545	547	GAC	210;208;205	G;A,C;C	194;188,1;187	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2560	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1372	183.2	1	SNP	p	D121N	0	.	.	361	363	GAC	545	547	GAC	210;208;205	G;A,C;C	194;188,1;187	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10006	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4844	206.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2013	2015	AAT	195;193;193	A,C;A;T	187,1;186;185	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1078	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	991	108.0	1	SNP	p	V57M	1	.	.	169	171	ATG	529	531	ATG	208;207;205	A;T;G	197;196;196	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
